MALE UROGENITAL DISEASES
Clinical trials for MALE UROGENITAL DISEASES explained in plain language.
Never miss a new study
Get alerted when new MALE UROGENITAL DISEASES trials appear
Sign up with your email to follow new studies for MALE UROGENITAL DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kidney cancer: vorolanib tested as Second-Line therapy
Disease control Recruiting nowThis study tests the drug vorolanib in people with advanced kidney cancer that cannot be removed by surgery or has spread. It is for patients who need a second treatment after the first one stopped working. The goal is to see how long the drug controls the cancer and what side ef…
Matched conditions: MALE UROGENITAL DISEASES
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 26, 2026 03:25 UTC
-
Immunotherapy-Chemo cocktail aims to wipe out penile cancer before surgery
Disease control Recruiting nowThis study tests whether giving a combination of chemotherapy (carboplatin/paclitaxel) and an immunotherapy drug (pembrolizumab) before surgery can completely eliminate cancer in men with advanced penile cancer that has spread to lymph nodes. About 27 participants will receive th…
Matched conditions: MALE UROGENITAL DISEASES
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 26, 2026 03:25 UTC
-
New immunotherapy combo may let some bladder cancer patients keep their bladder
Disease control Recruiting nowThis study tests whether giving two immunotherapy drugs (nivolumab and relatlimab) before surgery can help some patients with stage II-IIIa bladder cancer avoid bladder removal. About 90 participants will receive either one or both drugs, and doctors will check if the cancer disa…
Matched conditions: MALE UROGENITAL DISEASES
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 26, 2026 03:24 UTC
-
New hope for hard-to-treat prostate cancer: experimental drug combo enters human trials
Disease control Recruiting nowThis study tests a new drug called pocenbrodib, either alone or with other treatments, in people with a type of advanced prostate cancer that no longer responds to standard hormone therapy. The goal is to find the safest dose and see if it can shrink tumors or lower PSA levels. A…
Matched conditions: MALE UROGENITAL DISEASES
Phase: PHASE1, PHASE2 • Sponsor: Pathos AI, Inc. • Aim: Disease control
Last updated May 26, 2026 03:11 UTC